Clinical Trial Update: Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ACZ885 (canakinumab) in adults with established rheumatoid arthritis reports safety and efficacy outcomes. Results were posted for this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ACZ885 (canakinumab)

Snippet

Sponsor: Novartis | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2011-06-23